Showing results (91-100 of 133) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Rheumatology|March 25, 2017
Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritisBindee Kuriya, Orit Schieir, Daming Lin, et al.
The Lancet. Rheumatology|January 17, 2024
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trialStanley B Cohen, Janet Pope, Boulos Haraoui, et al.
Rheumatology (Oxford, England)|April 28, 2012
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohortEmily McKeown, Vivian P Bykerk, Faye De Leon, et al.
Arthritis Research & Therapy|September 11, 2015
Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patientsJosef S Smolen, Ronald van Vollenhoven, Arthur Kavanaugh, et al.
Annals of the Rheumatic Diseases|May 17, 2015
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritisGlen S Hazlewood, J Carter Thorne, Janet E Pope, et al.
Rheumatology (Oxford, England)|January 12, 2017
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritisLillian J Barra, Janet E Pope, Carol Hitchon, et al.
Arthritis Research & Therapy|March 2, 2006
Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changesJean-Pierre Raynauld, Johanne Martel-Pelletier, Marie-Josée Berthiaume, et al.
Arthritis Care & Research|June 9, 2022
Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational StudyBoulos Haraoui, Majed Khraishi, Denis Choquette, et al.
BMJ Open|September 1, 2017
Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registryProton Rahman, Michel Zummer, Louis Bessette, et al.
Arthritis Care & Research|August 27, 2016
Predicting Low Disease State and Remission in Early Rheumatoid Arthritis in the First Six Months, Comparing the Simplified Disease Activity Index and European League Against Rheumatism Response Measures: Results From an Early Arthritis CohortMohammed A Omair, Edward Keystone, Vivian Bykerk, et al.
Pageof 14